Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
10
83%
Ph phase_2
2
17%

Phase Distribution

10

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
10(83.3%)
Phase 2Efficacy & side effects
2(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(8)
Terminated(2)
Other(2)

Detailed Status

Completed8
unknown2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 110 (83.3%)
Phase 22 (16.7%)

Trials by Status

terminated18%
unknown217%
completed867%
withdrawn18%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_1

Targeted Fluorescence Imaging in AMD

NCT05262244
completedphase_1

Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW

NCT06095362
completedphase_1

VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions

NCT02129933
completedphase_1

Visualization of Rectal Cancer During Endoscopy, Using a Fluorescent Tracer

NCT01972373
terminatedphase_1

Fluorescence Endoscopy of Esophageal Carcinoma

NCT03558724
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05262244Phase 1

Targeted Fluorescence Imaging in AMD

Completed
NCT06095362Phase 1

Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW

Completed
NCT02129933Phase 1

VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions

Completed
NCT01972373Phase 1

Visualization of Rectal Cancer During Endoscopy, Using a Fluorescent Tracer

Completed
NCT03558724Phase 1

Fluorescence Endoscopy of Esophageal Carcinoma

Terminated
NCT02113202Phase 1

Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW

Completed
NCT04212793Phase 1

Detection of PitNET Tissue During TSS Using Bevacizumab-800CW

Completed
NCT05359874Phase 2

Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW

Withdrawn
NCT03620292Phase 1

Fluorescence Image Guided Surgery in Cholangiocarcinoma

Unknown
NCT03877601Phase 2

Detection of Early Esophageal Cancer by NIR-FME.

Unknown
NCT03913806Phase 1

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW

Completed
NCT01508572Phase 1

VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12